1. Hopes for fewer deaths, lower costs with genetics guiding dosing

   Media release 14 January 2013 Pages: 1 - 1

2. Prevenar and ActHib temporarily suspended in Japan

   News item 14 January 2013 Pages: 2 - 2

3. PPIs linked to hypomagnesaemia warns FDA

   News item 14 January 2013 Pages: 2 - 2

4. The US FDA is removing the boxed warning relating to liver injury from the labels of Letairis [ambrisentan] tablets,

   News item 14 January 2013 Pages: 2 - 2

5. The US FDA has announced that topiramate [Topamax] use in pregnant women has been linked to an increased chance of oral cleft

   News item 14 January 2013 Pages: 2 - 2

6. Warfarin's effect on stroke outcomes

   Clinical study 14 January 2013 Pages: 3 - 3

7. No link found between abacavir use and MI risk

   News item 14 January 2013 Pages: 3 - 3

8. ED and NSAIDs: study finding unexpected

   Clinical study 14 January 2013 Pages: 3 - 3

9. Detrimental effects of mercury 'undeniable'

   News item 14 January 2013 Pages: 4 - 4

10. Risk of some birth defects increased with opioid exposure

    Clinical study 14 January 2013 Pages: 4 - 4

11. Bivalirudin reduces platelet drop in ACS

    Clinical study 14 January 2013 Pages: 4 - 4

12. Amantadine

    Case report 14 January 2013 Pages: 5 - 5

13. Acetazolamide

    Case report 14 January 2013 Pages: 5 - 5

14. Amiodarone

    Case report 14 January 2013 Pages: 5 - 5

15. Adalimumab

    Case report 14 January 2013 Pages: 5 - 5

16. Amoxicillin/clavulanic acid

    Case report 14 January 2013 Pages: 6 - 6

17. Antineoplastics

    Case report 14 January 2013 Pages: 6 - 6

18. Antibacterials/herbal medicines/valproic acid

    Case report 14 January 2013 Pages: 6 - 6

19. Amiodarone

    Case report 14 January 2013 Pages: 6 - 6

20. Amoxicillin/ceftriaxone

    Case report 14 January 2013 Pages: 6 - 6

21. Antineoplastics/heparin

    Case report 14 January 2013 Pages: 7 - 7

22. Antineoplastics

    Case report 14 January 2013 Pages: 7 - 7

23. Antineoplastics

    Case report 14 January 2013 Pages: 7 - 7

24. Atazanavir/ritonavir

    Case report 14 January 2013 Pages: 8 - 8

25. Aprepitant/erlotinib

    Case report 14 January 2013 Pages: 8 - 8

26. Azithromycin/cefuroxime

    Case report 14 January 2013 Pages: 8 - 8

27. Aspirin/NSAIDs

    Case report 14 January 2013 Pages: 8 - 8

28. Bevacizumab

    Case report 14 January 2013 Pages: 9 - 9

29. Bevacizumab

    Case report 14 January 2013 Pages: 9 - 9

30. Bevacizumab

    Case report 14 January 2013 Pages: 9 - 9

31. BCG

    Case report 14 January 2013 Pages: 9 - 9

32. Bromisoval/lorazepam overdose

    Case report 14 January 2013 Pages: 10 - 10

33. Bevacizumab/cabozantinib/sunitinib

    Case report 14 January 2013 Pages: 10 - 10

34. Calcium carbonate/magnesium carbonate overdose

    Case report 14 January 2013 Pages: 10 - 10

35. Carbamazepine/chlorpromazine/risperidone

    Case report 14 January 2013 Pages: 10 - 11

36. Chloramphenicol

    Case report 14 January 2013 Pages: 11 - 11

37. Ciclosporin

    Case report 14 January 2013 Pages: 11 - 11

38. Carbon dioxide

    Case report 14 January 2013 Pages: 11 - 11

39. Clarithromycin

    Case report 14 January 2013 Pages: 12 - 12

40. Cotrimoxazole

    Case report 14 January 2013 Pages: 12 - 12

41. Clarithromycin

    Case report 14 January 2013 Pages: 12 - 12

42. Corticosteroids/mycophenolate mofetil/tacrolimus

    Case report 14 January 2013 Pages: 12 - 12

43. Clarithromycin/simvastatin interaction

    Case report 14 January 2013 Pages: 12 - 12

44. Cyclophosphamide

    Case report 14 January 2013 Pages: 13 - 13

45. Cyclophosphamide/methylprednisolone

    Case report 14 January 2013 Pages: 13 - 13

46. Cytarabine

    Case report 14 January 2013 Pages: 13 - 13

47. Cyclophosphamide/doxorubicin

    Case report 14 January 2013 Pages: 13 - 13

48. Dimetindene

    Case report 14 January 2013 Pages: 14 - 14

49. Diclofenac potassium

    Case report 14 January 2013 Pages: 14 - 14

50. Dimeticone

    Case report 14 January 2013 Pages: 14 - 14